TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04367883 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04367883 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04030429 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00733590 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03520634 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00219479 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03771105 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01240278 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT03441061 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03152058 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01456169 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01712529 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01712529 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00660816 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02526628 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06607354 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04789876 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03375619 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT03167203 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT00256724 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00171171 — Predictive Biomarker (PRD): Liver iron
Study NCT03461952 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT03461952 — Predictive Biomarker (PRD): POLD1 mRNA
Genes: POLD1; POLD
Study NCT03222687 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT04151433 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01334138 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01944124 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03172468 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00465088 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03468361 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04339829 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04417465 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04681820 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04681820 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02237196 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT03892395 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05528393 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT05528393 — Predictive Biomarker (PRD): PRLR mRNA
Genes: PRLR
Study NCT01807598 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT02134925 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT02352844 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02352844 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT02352844 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT02367027 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01902329 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT04346329 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01333046 — Predictive Biomarker (PRD): MAGEA4 mRNA
Genes: MAGEA4; MAGE4
Study NCT01333046 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT04494425 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04494425 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04494425 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04494425 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02579642 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01493973 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT00604630 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study NCT04674722 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02956408 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT04952324 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04952324 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02926638 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02926638 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT01279603 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT03065387 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03065387 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03065387 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT03065387 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04325126 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study NCT01456065 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT02360891 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT01625429 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03902223 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT02240511 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03232866 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00650845 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05499754 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05499754 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00546065 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04014465 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02645292 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04185298 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04185298 — Safety Biomarker (SAF): BDNF
Study NCT05178277 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT03504488 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study NCT02798978 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT00301418 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT00301418 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04197180 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT02342899 — Predictive Biomarker (PRD): SRI mRNA
Genes: SRI
Study NCT01684319 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study NCT04142437 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT00217373 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00217373 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04233112 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04126876 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study NCT01740804 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01740804 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01740804 — Predictive Biomarker (PRD): KIT
Genes: CD117; SCFR; C-Kit
Study NCT01740804 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04245813 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03573700 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03133546 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04440982 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT04116398 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02833727 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02833727 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03520842 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02981745 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05243199 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02394457 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00854451 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00167674 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02214290 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00515112 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01825785 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03607747 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00288678 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03881605 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01441804 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT03374215 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04222972 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT04273893 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00246129 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT02588261 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02588261 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02000622 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03839953 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02235844 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02235844 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03131518 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00334841 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study NCT00625963 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02759250 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT02424227 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04369742 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04369742 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04369742 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01726309 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01726309 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02159157 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01837277 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02446132 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02991469 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04143711 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04143711 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04143711 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01065454 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03157128 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT00126516 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04479150 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01306084 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02079077 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02079077 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01148381 — Predictive Biomarker (PRD): WNT2 mRNA
Genes: WNT2; INT1L1; IRP
Study NCT05301010 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03610191 — Predictive Biomarker (PRD): LY96 mRNA
Genes: LY96; ESOP1; MD2
Study NCT03610191 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT03610191 — Predictive Biomarker (PRD): LY96
Genes: MD-2
Study NCT03610191 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT03971565 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03971565 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03971565 — Predictive Biomarker (PRD): Chromosome 17p
Study NCT00940901 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT00940901 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02978794 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01758692 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02055209 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT02055209 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT02055209 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02055209 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04613596 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00922493 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT03838159 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04818255 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01521039 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT00477191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00477191 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00921791 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01369784 — Predictive Biomarker (PRD): IRF4 mRNA
Genes: IRF4; MUM1
Study NCT01922141 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03088488 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT03088488 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04267406 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05031195 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05031195 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT05031195 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02053636 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT02053636 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03693612 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04104776 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT01436994 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT04775446 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04775446 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02094651 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00933998 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00490646 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00383448 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT04187495 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study NCT03744793 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT01514539 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT04439448 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04439448 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04439448 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04219241 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03971409 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT02173925 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT02173925 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT02173925 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT03820635 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT00433784 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT04483960 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00932373 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02962778 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02962778 — Pharmacodynamic Biomarker (PDY): RAS peptides
Study NCT00673777 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00673777 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00673777 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT01663012 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01663012 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04126772 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT00656331 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02907684 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00720785 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT00720785 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02564978 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00955396 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03772262 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01143519 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05815953 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03712683 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT01557088 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT02159235 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02159235 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT02159235 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01098227 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00432406 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00860171 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT03261609 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02472301 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study NCT04532931 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03915964 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03647098 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03048175 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00520273 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00520273 — Monitoring Biomarker (MOI): HCV DNA
Study NCT04844164 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT01640704 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02612194 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01085149 — Predictive Biomarker (PRD): BMP2 mRNA
Genes: BMP2; BMP2A
Study NCT03602157 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03602157 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study NCT03814408 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03814408 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study NCT00612456 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01086306 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01107483 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT01107483 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01107483 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT01107483 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01107483 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03443362 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03443362 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01949090 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00987467 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02636530 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01761448 — Surrogate Endpoint (SUR): Blood pressure